Showing results 10 to 29 of 44
< previous
next >
| Issue Date | Title | Author(s) |
| 2020 | Did COVID-19 lockdown impact consumption of risky fairness creams in India? | Kumar, Abhay; Singhania, Ankita |
| 2020 | Did India’s price control policy for coronary stents create unintended consequences? | Deo, Sarang; Tyagi, Hanu; Chatterjee, Chirantan; Molakapuri, Himasagar |
| 1-Jan-2024 | Did the COVID-19 pandemic propel usage of AI in pharmaceutical innovation? New evidence from patenting data | Rathi, Sawan; Majumdar, Adrija; Chatterjee, Chirantan |
| 2020 | Fake news and misinformation | Shingi, Rashish Rajendra; Bhageria, Srishti |
| 2023 | Flattening the curve: COVID-19 & grand challenges for global health, innovation, and economy | - |
| 2019 | From courts to markets: new evidence on enforcement of pharmaceutical bans in India | Chatterjee, Chirantan; Mohapatra, D. P.; Estay, M. |
| 8-Jul-2019 | Future of sports and politics: historically, popular leaders have used sports to gain the legitimacy they desperately need | Chatterjee, Chirantan |
| 1-Dec-2022 | Generic competition and the incentives for early-stage pharmaceutical innovation | Branstetter, Lee; Chatterjee, Chirantan; Higgins, Matthew J. |
| 23-Mar-2022 | How do MNEs and domestic firms respond locally to a global demand shock? evidence from a pandemic | Chatterjee, Chirantan; Adbi, Arzi; Mishra, Anant |
| 9-Feb-2021 | How does regulation impact strategic repositioning by firms across submarkets? evidence from the Indian pharmaceutical industry | Bhaskarabhatla, Ajay; Anurag, Priyatam; Chatterjee, Chirantan; Pennings, Enrico |
| 2020 | Impact of non pharmaceutical (demand side) and pharmaceutical (supply side) intervention on spread of Covid-19 | Das, Manideepto; Metre, Sunita |
| 2020 | Impact of overseas opioid regulations on Indian opioid market | Reddy, Y. Chakradhar; Syamala, Samhitha |
| 2020 | Industry evolution in India’s vitamin C & D markets: evidence from 2007-2013 | Chauhan, Mayank; Joshi, Sitar |
| 19-Jul-2021 | Intellectual property regimes and wage inequality | Bhattacharya, Sourav; Chakraborty, Pavel; Chatterjee, Chirantan |
| 2020 | Interim report: GTM strategy for daytoday health for the Indian health insurance sector | Iyer, Avinash Chattanathan; Agarwal, Varun |
| 2022 | Markets, home country ecosystem partners & value creation: a study of Indian pharmaceutical industry | Aggarwal, Mayank |
| 16-Oct-2018 | A # me too Oktoberfest for women around the world | Chatterjee, Chirantan |
| 2-Feb-2023 | Movies, stigma and choice: evidence from the pharmaceutical industry | Aggarwal, Mayank; Chakrabarti, Anindya S.; Chatterjee, Chirantan |
| 20-Feb-2019 | Old drugs in a new avatar | Chatterjee, Chirantan |
| 12-Jul-2022 | Pandemics and technology engagement: new evidence from m-Health intervention during COVID-19 in India | Rathi, Sawan; Chakrabarti, Anindya S.; Chatterjee, Chirantan; Hegde, Aparna |
